The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 341:1550-1552 November 11, 1999 Number 20
NextNext

What's the Price of a Research Subject?

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Dickert, N.
-PubMed Citation
To the Editor: In their Sounding Board article on remuneration models for research subjects (July 15 issue),1 Dickert and Grady point out that payment of subjects is a common recruitment strategy, principally in trials sponsored by the pharmaceutical industry. The authors present a cogent argument based on ethical precepts for continuing this practice with both healthy volunteers and patient subjects. On review of three models (market, wage-payment, and reimbursement) for structuring payment to subjects, the authors advocate the uniform adoption of the wage-payment model as the most equitable and ethical approach.

We propose a fourth model for consideration: the fair-share . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.